Linked Data API

Show Search Form

Search Results

1140582
star this property registered interest false remove filter
star this property date less than 2019-07-19more like thismore than 2019-07-19
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when he plans to issue guidance to health professionals on the Serious Shortage Protocol. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 279389 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-26more like thismore than 2019-07-26
star this property answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-07-26T11:34:54.427Zmore like thismore than 2019-07-26T11:34:54.427Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property previous answer version
131086
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1140584
star this property registered interest false remove filter
star this property date less than 2019-07-19more like thismore than 2019-07-19
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans the Government has provide information to patients on changes to the provision of medicines as a result of the serious shortage protocol; and if he will make a statement. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 279390 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-26more like thismore than 2019-07-26
star this property answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 279391 more like this
star this property question first answered
less than 2019-07-26T11:36:12.94Zmore like thismore than 2019-07-26T11:36:12.94Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property previous answer version
131087
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1140585
star this property registered interest false remove filter
star this property date less than 2019-07-19more like thismore than 2019-07-19
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions the Government has had with (a) patient groups and (b) professional bodies on the development of the serious shortage protocol. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 279391 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-26more like thismore than 2019-07-26
star this property answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 279390 more like this
star this property question first answered
less than 2019-07-26T11:36:13.003Zmore like thismore than 2019-07-26T11:36:13.003Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property previous answer version
131085
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1143605
star this property registered interest false remove filter
star this property date less than 2019-09-02more like thismore than 2019-09-02
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading HIV Infection: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) raise awareness of and (b) increase access to the PrEP impact trial in BAME communities. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 285065 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-09-05more like thismore than 2019-09-05
star this property answer text <p>A core function of the pre-exposure prophylaxis (PrEP) Impact Trial Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations including women and black, Asian and minority ethnic (BAME) communities. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following links:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/</a></p><p><a href="https://www.prepimpacttrial.org.uk/faqs" target="_blank">https://www.prepimpacttrial.org.uk/faqs</a></p><p>In addition, Public Health England’s Innovation Fund has supported a number of community based projects aimed at increasing PrEP awareness in women, BAME groups and trans communities; information on the projects funded in 2018 can be found at the following links:</p><p><a href="https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018" target="_blank">https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018</a></p><p>Since the start of the PrEP Impact Trial in October 2017, over half of the available 26,000 trial places have been filled. As of 3 September 2019, all participating Trial clinics were open to recruitment for women, trans men and heterosexual men. Information on the enrolment status of participating clinics is regularly updated on the PrEP Impact Trial website at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/join-the-trial" target="_blank">https://www.prepimpacttrial.org.uk/join-the-trial</a></p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 285069 more like this
star this property question first answered
less than 2019-09-05T15:28:31.897Zmore like thismore than 2019-09-05T15:28:31.897Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1143606
star this property registered interest false remove filter
star this property date less than 2019-09-02more like thismore than 2019-09-02
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading HIV Infection: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) raise awareness of and (b) increase access to the PrEP impact trial amongst women at high risk of contracting HIV. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 285069 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-09-05more like thismore than 2019-09-05
star this property answer text <p>A core function of the pre-exposure prophylaxis (PrEP) Impact Trial Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations including women and black, Asian and minority ethnic (BAME) communities. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following links:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/</a></p><p><a href="https://www.prepimpacttrial.org.uk/faqs" target="_blank">https://www.prepimpacttrial.org.uk/faqs</a></p><p>In addition, Public Health England’s Innovation Fund has supported a number of community based projects aimed at increasing PrEP awareness in women, BAME groups and trans communities; information on the projects funded in 2018 can be found at the following links:</p><p><a href="https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018" target="_blank">https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018</a></p><p>Since the start of the PrEP Impact Trial in October 2017, over half of the available 26,000 trial places have been filled. As of 3 September 2019, all participating Trial clinics were open to recruitment for women, trans men and heterosexual men. Information on the enrolment status of participating clinics is regularly updated on the PrEP Impact Trial website at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/join-the-trial" target="_blank">https://www.prepimpacttrial.org.uk/join-the-trial</a></p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 285065 more like this
star this property question first answered
less than 2019-09-05T15:28:31.943Zmore like thismore than 2019-09-05T15:28:31.943Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
964345
star this property registered interest false remove filter
star this property date less than 2018-09-03more like thismore than 2018-09-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Self-harm: Children more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many (a) boys and (b) girls aged (i) 0-10, (ii) 11-13, (iii) 14, (iv) 15 and (v) 16 and 17 years old have been admitted to hospital in England as a result of (A) self-harm and (B) self-poisoning in each year since 2015. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 169127 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-09-11more like thismore than 2018-09-11
star this property answer text <p>A count of finished admission episodes (FAEs) with an external cause of self-harm and self-poisoning for boys and girls aged 0-10, 11-13, 14, 15 and 16 and 17 years old in England for the years 2014-15 to 2016-17 is shown in the attached table owing to its size.</p><p> </p><p>An FAE is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period.</p> more like this
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property question first answered
less than 2018-09-11T10:42:59.247Zmore like thismore than 2018-09-11T10:42:59.247Z
star this property answering member
4065
star this property label Biography information for Jackie Doyle-Price more like this
star this property attachment
1
star this property file name PQ169127 format.xlsx more like this
star this property title PQ169127 attached document more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1039003
star this property registered interest false remove filter
star this property date less than 2019-01-10more like thismore than 2019-01-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Epilepsy: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether he plans to exclude epilepsy medications from the Serious Shortage Protocol for medicines; and if he will make a statement. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 207181 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-01-15more like thismore than 2019-01-15
star this property answer text <p>Any serious shortage protocol would be developed with and signed off by clinicians. Only if clinicians deem it appropriate, an alternative quantity, strength, pharmaceutical form or medicine can be dispensed in line with the protocol. Each protocol would clearly set out what action can be taken by the retail pharmacy, under what circumstances, for which patients and during which period.</p><p> </p><p>Protocols for therapeutic or generic equivalents will not be suitable for all medicines and patients. For example, they would not be suitable for treatments where the medicines that are prescribed need to be prescribed by brand for clinical reasons, for example anti-epilepsy medicines. In these cases, patients would always be referred back to the prescriber for any decision about their treatment before any therapeutic or generic alternative is supplied.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2019-01-15T16:16:17.813Zmore like thismore than 2019-01-15T16:16:17.813Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1023254
star this property registered interest false remove filter
star this property date less than 2018-12-11more like thismore than 2018-12-11
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Healthcare Environmental Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to the Written Statement of 11 December 2018 on Clinical Waste, Official Report, HCWS1168, if he will publish the NHS trusts that continue to receive services from Healthcare Environmental Services. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 201130 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-12-17more like thismore than 2018-12-17
star this property answer text <p>As of 13 December, no National Health Service trusts with remaining contacts in place with Healthcare Environment Services are reporting that they are continuing to receive their scheduled clinical waste collections from Healthcare Environmental Services. Contingency arrangements are in place for each of the affected trusts. An optional extension in the Mitie contract has been exercised, which will allow all affected trusts to access a replacement clinical waste collection service, should they choose to do so.</p> more like this
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond more like this
star this property question first answered
less than 2018-12-17T17:40:40.473Zmore like thismore than 2018-12-17T17:40:40.473Z
star this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
923314
star this property registered interest false remove filter
star this property date less than 2018-06-13more like thismore than 2018-06-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Pneumonia: Vaccination more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many stakeholders the Joint Committee on Vaccination and Immunisation has consulted on the revised schedule for the infant pneumococcal immunisation programme since its meeting of 7 February 2018. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 153218 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-06-21more like thismore than 2018-06-21
star this property answer text <p>As part of a stakeholder consultation on the childhood pneumococcal vaccination schedule, responses were sought from Pfizer, GlaxoSmithKline, Merck, Meningitis Now, and the Meningitis Research Foundation. Additional responses were received from the Confederation of Meningitis Organisations, the International Federation of Ageing, and the International Longevity Centre.</p><p> </p><p>The Joint Committee on Vaccination and Immunisation (JCVI) Pneumococcal sub-committee considered the responses received on 10 May 2018. The sub-committee reported to the JCVI on 6 June 2018. The minutes of these meetings will provide the Committee’s response to points raised during the consultation and will be published on or before 18 July 2018.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property grouped question UIN 153219 more like this
star this property question first answered
less than 2018-06-21T16:04:05.46Zmore like thismore than 2018-06-21T16:04:05.46Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
923315
star this property registered interest false remove filter
star this property date less than 2018-06-13more like thismore than 2018-06-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Pneumonia: Vaccination more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether the Joint Committee on Vaccination and Immunisation will respond to all stakeholder submissions on the proposal to reduce the number of doses in the infant pneumococcal vaccination programme. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 153219 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-06-21more like thismore than 2018-06-21
star this property answer text <p>As part of a stakeholder consultation on the childhood pneumococcal vaccination schedule, responses were sought from Pfizer, GlaxoSmithKline, Merck, Meningitis Now, and the Meningitis Research Foundation. Additional responses were received from the Confederation of Meningitis Organisations, the International Federation of Ageing, and the International Longevity Centre.</p><p> </p><p>The Joint Committee on Vaccination and Immunisation (JCVI) Pneumococcal sub-committee considered the responses received on 10 May 2018. The sub-committee reported to the JCVI on 6 June 2018. The minutes of these meetings will provide the Committee’s response to points raised during the consultation and will be published on or before 18 July 2018.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property grouped question UIN 153218 more like this
star this property question first answered
less than 2018-06-21T16:04:05.507Zmore like thismore than 2018-06-21T16:04:05.507Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this